Clinical Trial Update: Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA) [Phase 1, Phase 2]

View source ↗

Summary

This document reports the status of a Phase 1/2 clinical trial evaluating trifluridine/tipiracil (Lonsurf) in metastatic breast cancer patients, with or without…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lonsurf (trifluridine/tipiracil)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING